Want to join the conversation?
$BAX's sales in the Renal segment for 2015 declined by 9% from last year. Foreign currencies had an unfavorable foreign currency impact of 10 percentage points in 2015. Sales in Renal segment rose 1% on constant currency basis, driven by continued growth in number of PD patients globally and strong demand in the acute business.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?